What is ProSurg?
ProSurg Inc. is a privately held medical device firm headquartered in Silicon Valley, California. The company specializes in the development and commercialization of advanced medical products tailored for minimally invasive prostate surgery, abnormal uterine bleeding, and other urological and gynecological conditions. ProSurg's product portfolio is engineered for seamless integration with existing endoscopic instruments and RF generators, featuring proprietary innovations such as the NeoScope and Salinetrode Flex. Their strategic focus is on delivering cutting-edge solutions to healthcare professionals engaged in minimally invasive surgical procedures.
How much funding has ProSurg raised?
ProSurg has raised a total of $106K across 1 funding round:
Debt
$106K
Debt (2021): $106K with participation from PPP
What's next for ProSurg?
The recent major strategic investment into ProSurg signals a critical juncture for the company, likely aimed at accelerating product development, expanding market reach, and potentially preparing for further growth phases or strategic partnerships. As a company operating within the dynamic medical technology landscape, this capital infusion is expected to fuel innovation and solidify its position in urological and gynecological surgical solutions. The late-stage funding context suggests a focus on commercialization and market penetration, leveraging their advanced product offerings to capture greater market share.
See full ProSurg company page
